标题
Immunogenicity of therapeutic recombinant immunotoxins
作者
关键词
-
出版物
IMMUNOLOGICAL REVIEWS
Volume 270, Issue 1, Pages 152-164
出版商
Wiley
发表日期
2016-02-12
DOI
10.1111/imr.12390
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads
- (2015) Regina S. Salvat et al. BIOTECHNOLOGY AND BIOENGINEERING
- Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivo
- (2015) Ronit Mazor et al. Cellular & Molecular Immunology
- Poor correlation between T-cell activation assays and HLA-DR binding prediction algorithms in an immunogenic fragment of Pseudomonas exotoxin A
- (2015) Ronit Mazor et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Bortezomib Reduces Pre-Existing Antibodies to Recombinant Immunotoxins in Mice
- (2015) Michael L. Manning et al. JOURNAL OF IMMUNOLOGY
- Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors
- (2015) R. Mazor et al. MOLECULAR CANCER THERAPEUTICS
- Advances in Anticancer Immunotoxin Therapy
- (2015) C. Alewine et al. ONCOLOGIST
- Identification of Immunodominant CD4-Restricted Epitopes Co-Located with Antibody Binding Sites in Individuals Vaccinated with ALVAC-HIV and AIDSVAX B/E
- (2015) Silvia Ratto-Kim et al. PLoS One
- Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen
- (2014) Raffit Hassan et al. CANCER
- Tofacitinib Suppresses Antibody Responses to Protein Therapeutics in Murine Hosts
- (2014) M. Onda et al. JOURNAL OF IMMUNOLOGY
- An improved recombinant Fab-immunotoxin targeting CD22 expressing malignancies
- (2014) Tapan K. Bera et al. LEUKEMIA RESEARCH
- In Vitro and In Vivo Activity of the Low-Immunogenic Antimesothelin Immunotoxin RG7787 in Pancreatic Cancer
- (2014) K. Hollevoet et al. MOLECULAR CANCER THERAPEUTICS
- Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers
- (2014) C. Alewine et al. MOLECULAR CANCER THERAPEUTICS
- Removing T-cell epitopes with computational protein design
- (2014) C. King et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
- (2014) R. Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of Mesothelin in Tumor Progression and Targeted Therapy
- (2013) Zhewei Tang et al. Anti-Cancer Agents in Medicinal Chemistry
- Shaping T Cell – B Cell Collaboration in the Response to Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 by Peptide Priming
- (2013) N. Kalaya Steede et al. PLoS One
- Major Cancer Regressions in Mesothelioma After Treatment with an Anti-Mesothelin Immunotoxin and Immune Suppression
- (2013) R. Hassan et al. Science Translational Medicine
- Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
- (2012) Robert J. Kreitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A
- (2012) R. Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody Fusion Proteins: Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox
- (2011) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo
- (2011) Leonard Moise et al. CLINICAL IMMUNOLOGY
- A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer
- (2011) John E. Weldon et al. FEBS Journal
- Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift
- (2011) J. R. Cantor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes
- (2011) M. Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial
- (2010) A. S. Wayne et al. CLINICAL CANCER RESEARCH
- Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass Allergen
- (2010) C. Oseroff et al. JOURNAL OF IMMUNOLOGY
- A Recombinant Immunotoxin Targeting CD22 With Low Immunogenicity, Low Nonspecific Toxicity, and High Antitumor Activity in Mice
- (2010) Johanna K. Hansen et al. JOURNAL OF IMMUNOTHERAPY
- Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
- (2010) Frank R. Brennan et al. mAbs
- Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics☆
- (2009) Satoshi Nagata et al. ADVANCED DRUG DELIVERY REVIEWS
- Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
- (2009) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Reducing risk, improving outcomes: Bioengineering less immunogenic protein therapeutics
- (2009) Anne S. De Groot et al. CLINICAL IMMUNOLOGY
- Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies
- (2009) Robert Kreitman CURRENT PHARMACEUTICAL DESIGN
- Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia
- (2009) Robert J. Kreitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin
- (2009) Jeannick Cizeau et al. JOURNAL OF IMMUNOTHERAPY
- How to systematically evaluate immunogenicity of therapeutic proteins – regulatory considerations
- (2009) Eva-Maria Jahn et al. New Biotechnology
- A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity
- (2008) J. E. Weldon et al. BLOOD
- Translational applications of antibody phage display
- (2008) Don L. Siegel IMMUNOLOGIC RESEARCH
- An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
- (2008) M. Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started